---
category: listing
circular_id: 7064ac4bfd2c8d21
date: '2025-11-17'
description: BSE circular regarding the listing of equity shares of Mahamaya Lifesciences
  Limited on the exchange.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={1D7FF0AD-BB5D-4E84-89B9-3CCF98D9EBBE}&noticeno=20251117-58&dt=11/17/2025&icount=58&totcount=66&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: New equity listing on BSE - impacts trading availability for investors
  interested in Mahamaya Lifesciences Limited
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251117-58&attachedId=1a4d37b9-0d26-4fc1-bd16-86c0d4f30962
processing:
  attempts: 1
  content_hash: 8bd851d97e67879f
  processed_at: '2025-11-17T15:31:38.978734'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-17T14:04:05+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={1D7FF0AD-BB5D-4E84-89B9-3CCF98D9EBBE}&noticeno=20251117-58&dt=11/17/2025&icount=58&totcount=66&flag=0
severity: medium
source: bse
stocks:
- MAHAMAYA
tags:
- equity
- listing
title: Listing of Equity Shares of MAHAMAYA LIFESCIENCES LIMITED
---

## Summary

BSE has announced the listing of equity shares of Mahamaya Lifesciences Limited on the exchange. This circular provides information about the newly listed securities.

## Key Points

- Company Name: Mahamaya Lifesciences Limited
- Listing Date: November 17, 2025
- Security Type: Equity Shares
- Exchange: BSE (Bombay Stock Exchange)

## Regulatory Changes

No regulatory changes announced in this circular.

## Compliance Requirements

- The company must comply with all listing agreement requirements
- Regular disclosure and reporting obligations as per SEBI regulations
- Adherence to corporate governance norms

## Important Dates

- Listing Date: November 17, 2025
- Circular Issue Date: November 17, 2025

## Impact Assessment

The listing of Mahamaya Lifesciences Limited equity shares provides investors with a new investment opportunity in the lifesciences sector. The stock will now be available for trading on BSE, enhancing market depth and providing liquidity to existing shareholders.